fda warns hims & hers for selling unapproved compounded semaglutide Health stock tanks after says competitor Eli Lilly's weight-loss drug shortage is over Compounded "semaglutide" is not FDA-approved

Nat Protoc 2006

The opposing effects of cannabinoids (either improving or worsening intestinal permeability) might be related to the recent observation that endocannabinoids such as anandamide worsen permeability while phytocannabinoids like cannabidiol and tetrahydrocannabidiol, which might act as (partial) CB1R antagonists, promote protection or recovery from intestinal permeability [52]

The big GLP-1 story of 2026 has been the arrival of the pills that have taken both Europe and the US by storm

It adds that herbal compounds do not replace pharmaceutical interventions that require medical supervision, and routes readers to a qualified provider for personalized recommendations

doi: 10.1080/01616412.2025.2524741 [Epub ahead of print]

For patients using insulin or sulfonylureas, reducing their doses by 25% when starting GLP-1 therapy can help avoid hypoglycemia